Latest Breaking News On - ஆமி ஸ்சுழ்மான் - Page 1 : comparemela.com

Lyndra Therapeutics Closes $60 5M Series C Financing

Lyndra Therapeutics Closes $60.5M Series C Financing Lyndra Therapeutics, a Watertown, Mass.-based clinical-stage biotechnology company pioneering a novel technology platform that transforms daily pills into once-weekly to monthly oral treatment options, closed a $60.5m Series C financing. The round was led by new investor, AIG Investments, an affiliate of American International Group with participation from new investors Yipinhong Pharmaceutical (USA) Limited, Limitless Ventures and the Catalytic Impact Foundation with ImpactAssets, and existing investors Polaris Partners, Invus, Quark Venture, Mass General Brigham Ventures, HOPU Investments, and Gilead Sciences, Inc. The company intends to use the funds to advance its lead product candidate into pivotal trials as they prepare for commercialization in the U.S., expand its central nervous system (CNS) pipeline assets and actively evaluate high value partnerships across a broad range of disease states.

United statesPatricia hurterAmy schulmanYipinhong pharmaceutical united statesAmerican international groupGilead sciences incImpact foundationLyndra therapeuticsYipinhong pharmaceuticalLimitless venturesCatalytic impact foundationPolaris partnersQuark ventureMass general brigham venturesGilead sciencesChief executive officer

Thirty Madison Raises $140M in Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Steven gutentagAmy schulmanJason stofferRandy scottJjdc incThirty madisonNew york basedHealthquest capitalMousse partnersBracket capitalPolaris partnersJohnson innovationManaging partnerஆமி ஸ்சுழ்மான்ரேண்டி ஸ்காட்முப்பது மாடிசன்

New Fund for Early-Stage Life Sciences, Microscopy for Protein Dynamics: Follow the Money

New Fund for Early-Stage Life Sciences, Microscopy for Protein Dynamics: Follow the Money
bio-itworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio-itworld.com Daily Mail and Mail on Sunday newspapers.

United statesMorgan stanleyGennao bioDavid waltRobert tjianEric betzigLuke lavisViva bioinnovatorRogerm perlmutterXavier darzacqAmy schulmanPeter glazerAndreessen horowitzStephen squintoElias quijanoBruce turner

Thirty Madison Raises $140 Million in Series C Financing Led by HealthQuest Capital

/PRNewswire/ Thirty Madison, the premier healthcare company for people with chronic conditions, today announced a $140 million Series C round led by new.

United statesSteven gutentagAmy schulmanJason stofferRandy scottJjdc incMousse partnersBracket capitalPolaris partnersJohnson innovationThirty madisonManaging partnerSan francisco bay areaCquest capitalஒன்றுபட்டது மாநிலங்களில்ஆமி ஸ்சுழ்மான்

Engine Biosciences Raises $43M in Series A Funding

Engine Biosciences, Singapore- and San Carlos, CA-based company deciphering complex biology to create medicines , raised $43m in Series A funding round. The round was led by Polaris Partners qith participation from new investors Invus and one of the world’s premier institutional investors, based in Singapore, as well as existing investors 6 Dimensions Capital, WuXi AppTec, DHVC, EDBI, Baidu Ventures, Vectr Ventures, Goodman Capital, WI Harper, and Nest.Bio. Amy Schulman, Managing Partner at Polaris Partners, has joined the Engine Biosciences Board of Directors. The company, which has now raised $53m to date, including $10m in a 2018 seed round, intends to use the funds to to expand its portfolio of precision oncology therapeutics, prepare for its first clinical programs, and scale its proprietary technology platform.

Jeffrey luAmy schulmanEngine biosciencesSan carlosPolaris partnersWuxi apptecBaidu venturesVectr venturesGoodman capitalManaging partnerEngine biosciences boardஜெஃப்ரி லுஆமி ஸ்சுழ்மான்இயந்திரம் உயிர் அறிவியல்சான் கார்லோஸ்போழரிச் கூட்டாளர்கள்